BLOOMBERG Bloomberg Daybreak Europe July 18, 2017
Have a stacked up show for you, were going to talk about the drug sector, i wonder what the ceo of nevadas is going to say about health care in the United States. In fact, it looks as though we are getting some numbers through right now. A fouryear numbers to be broadly in line and confirming the Group Outlook for 2017. They are a Second Quarter core eps, reading estimates, one of the biggest headlines. Broadly in line, that one seems to be. 1. 22, thenumber, estimate was 1. 18. Looks like the core number has beat the estimate. We will speak with the ceo later on during the program. This is th...
Source: archive.org